NEW YORK (Reuters Health) – Epoetin alpha can reduce the number of erythrocyte transfusions needed in patients with acute leukemia undergoing myelosuppressive chemotherapy, without affecting length of remission,…
NEW YORK (Reuters Health) – A new study suggests that, in a real-world setting, adjuvant chemotherapy in adults over age 65 with stage II colon cancer and high-risk…
NEW YORK (Reuters Health) – A new report concludes that expectant management of severe preeclampsia occurring before 34 weeks gestation is appropriate in selected cases. It can prolong…
NEW YORK (Reuters Health) – No chemotherapy sensitivity and resistance assays have sufficient supporting evidence to justify their use in oncology practice. That’s the conclusion of an American…
NEW YORK (Reuters Health) – Kidney failure during hemolytic uremic syndrome is less likely to develop in children with diarrhea due to virulent E. coli infection if they’re…
NEW YORK (Reuters Health) – In women undergoing breast-conserving therapy for early breast cancer, the presence of occult metastasis not seen with routine pathological examination in sentinel lymph…
NEW YORK (Reuters Health) – A 4-year placebo-controlled trial of alpha-lipoic acid to treat diabetes-related polyneuropathy produced no improvement in the study’s composite endpoint, but there were clinically…
NEW YORK (Reuters Health) – Patients with aortic stenosis fare better when they’re treated with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs), results of a population-based…
NEW YORK (Reuters Health) – Oral propranolol given for 6 months stops the growth of infantile hemangiomas and decreases their volume and coloration, according to the results of…
NEW YORK (Reuters Health) – Over the past nearly 30 years, survivors of myocardial infarction have suffered an increasing rate of osteoporotic fractures, a new population-based cohort study…